Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation

Following allogeneic blood and marrow transplantation (BMT), graft-versus-host disease (GvHD) continues to represent a significant cause of treatment failure, despite the routine use of conventional, mainly calcineurin inhibitor-based prophylaxis. Recently, post-transplant cyclophosphamide (PTCy) ha...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Louis Williams, Frank Cirrone, Kelli Cole, Maher Abdul-Hay, Leo Luznik, Ahmad Samer Al-Homsi
التنسيق: مقال
اللغة:English
منشور في: Frontiers Media S.A. 2020-04-01
سلاسل:Frontiers in Immunology
الموضوعات:
GvHD prevention
post-transplant cyclophosphamide
matched-related donor
matched unrelated donor
bortezomib
calcineurin inhibitor-free
الوصول للمادة أونلاين:https://www.frontiersin.org/article/10.3389/fimmu.2020.00636/full

الانترنت

https://www.frontiersin.org/article/10.3389/fimmu.2020.00636/full

مواد مشابهة